0.50

16.17% 0.0696

After Hours: .48 -0.02 -4.00%

Fractyl Health Inc (GUTS)

Overview News Price History Discussions Forecast

Fractyl Health Inc stock is traded at $0.50, with a volume of 7.34M. It is up +16.17% in the last 24 hours and down -1.19% over the past month. Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

Previous Close:

$0.4304

Open:

$0.49

24h Volume:

7.34M

Relative Volume:

1.37

Market Cap:

$76.69M

Revenue:

$3,000

Net Income/Loss:

$-122.20M

P/E Ratio:

-0.2201

EPS:

-2.272

Net Cash Flow:

$-86.81M

1W Performance:

+12.38%

1M Performance:

-1.19%

6M Performance:

-50.50%

1Y Performance:

-59.35%

1-Day Range:

$0.455

$0.50

1-Week Range:

$0.4167

$0.50

52-Week Range:

$0.3772

$3.03

Fractyl Health Inc Stock (GUTS) Company Profile

Name

Fractyl Health Inc

Sector

Healthcare (1114)

Industry

Biotechnology (623)

Phone

781-902-8800

Address

3 VAN DE GRAAFF DRIVE, BURLINGTON

Employee

109

Twitter

Next Earnings Date

2026-03-24

Latest SEC Filings

GUTS's Discussions on Twitter

Compare GUTS vs VRTX, REGN, ALNY, ARGX, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GUTS Fractyl Health Inc	0.50	66.01M	3,000	-122.20M	-86.81M	-2.272
VRTX Vertex Pharmaceuticals Inc	454.97	113.96B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	749.47	78.41B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.70	40.85B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	697.05	42.05B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	148.31	29.99B	606.42M	-1.28B	-997.58M	-6.403

Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-30-26	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Sep-15-25	Initiated	H.C. Wainwright	Buy
Aug-28-25	Initiated	Ladenburg Thalmann	Buy
Feb-28-24	Initiated	Evercore ISI	Outperform
Feb-27-24	Initiated	BofA Securities	Buy
Feb-27-24	Initiated	Morgan Stanley	Overweight

View All

Fractyl Health Inc Stock (GUTS) Latest News

Mar 25, 2026

BofA Securities Maintains Fractyl Health(GUTS.US) With Buy Rating - Moomoo

Mar 25, 2026

Fractyl Health (GUTS) Stock Jumps 21% After Hours: Here's What You Should Know - Benzinga

Mar 25, 2026

Fractyl Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 25, 2026

Fractyl Health Inc (GUTS)

Fractyl Health Inc Stock (GUTS) Company Profile

Compare GUTS vs VRTX, REGN, ALNY, ARGX, INSM

Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades

Fractyl Health Inc Stock (GUTS) Latest News

BofA Securities Maintains Fractyl Health(GUTS.US) With Buy Rating - Moomoo

Fractyl Health (GUTS) Stock Jumps 21% After Hours: Here's What You Should Know - Benzinga

Fractyl Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Fractyl Health Inc (GUTS) Q4 2025 Earnings Call Highlights: Navigating Financial Challenges ... By GuruFocus - Investing.com Canada

Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4 - MSN

Disease-Modifying Therapies for Obesity and Type 2 Diabetes: Revita and Rejuva Pipeline Overview - Minichart

Fractyl Health Inc’s 2025 Q4 Call: CPT Code Timing, Regulatory Readiness, and Ablation Targets Don’t Align - Bitget

GUTS: Pivotal study enrollment complete; Revita advances toward key 2026 data and de novo submission - TradingView

Fractyl Health Q4 Earnings Call Highlights - Yahoo Finance

Earnings call transcript: Fractyl Health Q4 2025 sees cost cut, stock dips - Investing.com

Fractyl Health (NASDAQ:GUTS) Posts Narrower-Than-Expected Loss Ahead of Pivotal Trial Readout - ChartMill

FRACTYL HEALTH ($GUTS) Releases Q4 2025 Earnings - Quiver Quantitative

Fractyl Highlights Revita Progress and 2025 Financial Results - TipRanks

Fractyl Health (NASDAQ:GUTS) Releases Earnings Results, Misses Expectations By $0.13 EPS - MarketBeat

Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates - The Manila Times

Fractyl Health 2025 10-K: $0M Revenue, Net Loss $140.954M - TradingView

Fractyl Health (NASDAQ: GUTS) outlines Revita device and Rejuva gene therapy plans - Stock Titan

Fractyl Health (Nasdaq: GUTS) widens 2025 loss but advances pivotal Revita - Stock Titan

If You Invested $1,000 in Fractyl Health (GUTS) - Stock Titan

Fractyl Health, Inc. (GUTS) loses 77.6% in 4 weeks, here's why a trend reversal may be around the corner - MSN

Fractyl Health (NASDAQ:GUTS) - intelligentinvestor.com.au

H.C. Wainwright Maintains a Buy Rating on Fractyl Health, Inc. (GUTS) with an $8 Price Target - Insider Monkey

Fractyl Health, Inc. (GUTS) moves to buy: Rationale behind the upgrade - MSN

Fractyl Health Receives Nasdaq Minimum Bid Price Notice - The Globe and Mail

Fractyl Health (Nasdaq: GUTS) faces Nasdaq minimum bid-price warning - Stock Titan

Portfolio Shifts: Is Fractyl Health Inc undervalued by DCF analysis2026 Chart Watch & Free Safe Capital Growth Stock Tips - baoquankhu1.vn

Fractyl Health to report fourth quarter and full year 2025 financial results and provide business updates on March 24, 2026 - marketscreener.com

Fractyl Health To Report Fourth Quarter And Full Year 2025 Financial Results And Provide Business Updates On March 24, 2026 - TradingView

Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026 - The Manila Times

Investment Report: What is the dividend yield of Fractyl Health Inc2026 Valuation Update & Growth Oriented Trade Recommendations - baoquankhu1.vn

Fractyl Health, Inc. (GUTS) Initiates Purchase: Reasons for the Rating Increase - Bitget

Rosalind Advisors Inc. Takes Position in Fractyl Health, Inc. $GUTS - MarketBeat

Does Fractyl Health Inc have pricing powerMarket Growth Review & Low Risk High Win Rate Stock Picks - baoquankhu1.vn

Fractyl Health announces proposed public offering - MSN

Aug Reactions: What is the dividend yield of Fractyl Health IncWeekly Stock Recap & Expert Curated Trade Setup Alerts - baoquankhu1.vn

Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

GUTS Technical Analysis & ETF Price Forecast - Intellectia AI

GUTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Fractyl Health Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView

Fractyl Completes Randomization in REMAIN-1 Revita Trial - The Globe and Mail

Fractyl Health completes randomization in Remain-1 pivotal cohort of Revita® - marketscreener.com

Fractyl Health Completes Randomization In Remain-1 Pivotal Cohort Of Revita® - TradingView

Fractyl Health completes randomization in REMAIN-1; topline 6-month data due early Q4 2026 - TradingView

Fractyl Health (GUTS) hits Revita pivotal trial milestone, eyes 2026 FDA filing - Stock Titan

Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight Maintenance - GlobeNewswire

Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita for Post-GLP-1 Weight Maintenance - Bitget

GUTS SEC FilingsFractyl Health 10-K, 10-Q, 8-K Forms - Stock Titan

Fractyl Health, Inc. (GUTS) Loses 77.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz

Fractyl Health (GUTS) Projected to Post Quarterly Earnings on Monday - MarketBeat

Should I buy Fractyl Health, Inc. (GUTS) - Zacks Investment Research

GUTSFractyl Health Latest Stock News & Market Updates - Stock Titan

Fractyl Health Inc Stock (GUTS) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to GUTS